Amaris K. Balitsky

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Correction: Development of an Electronic Learning Module for CAR-T Education in Canadian Hematology Residents.

Correction: Development of an Electronic Learning Module for CAR-T Education in Canadian Hematology Residents.

Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: April 08, 2026

Development of an Electronic Learning Module for CAR-T Education in Canadian Hematology Residents.

Development of an Electronic Learning Module for CAR-T Education in Canadian Hematology Residents.

Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: December 16, 2025

Development of an Electronic Learning Module for CAR-T Education in Canadian Hematology Residents.

Development of an Electronic Learning Module for CAR-T Education in Canadian Hematology Residents.

Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: December 16, 2025

Secondary primary malignancies in indolent non-Hodgkin lymphoma patients receiving frontline bendamustine-rituximab.

Secondary primary malignancies in indolent non-Hodgkin lymphoma patients receiving frontline bendamustine-rituximab.

Journal: Cancer
Published: October 14, 2025

CAR-T for Management of R/R PTLD Following Lung Transplant: A Multi-center Retrospective Study.

CAR-T for Management of R/R PTLD Following Lung Transplant: A Multi-center Retrospective Study.

Journal: Transplantation and cellular therapy
Published: August 28, 2025

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias.

Immunogenicity and safety of a third and subsequent COVID-19 vaccine doses in patients with plasma cell dyscrasias.

Journal: Blood advances
Published: August 18, 2025

Immunogenicity and Safety of a Third and Subsequent COVID-19 Vaccine Doses in Patients with Plasma Cell Dyscrasias.

Immunogenicity and Safety of a Third and Subsequent COVID-19 Vaccine Doses in Patients with Plasma Cell Dyscrasias.

Journal: Blood advances
Published: August 18, 2025

Changes in Frailty Categorization Over One Year among Real-World Patients With Multiple Myeloma: A Prospective Cohort Study (MFRAIL).

Changes in Frailty Categorization Over One Year among Real-World Patients With Multiple Myeloma: A Prospective Cohort Study (MFRAIL).

Journal: Clinical lymphoma, myeloma & leukemia
Published: July 10, 2025

Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy.

Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy.

Journal: Transplantation and cellular therapy
Published: July 10, 2025

Revaccination following CAR-T therapy: a needs assessment.

Revaccination following CAR-T therapy: a needs assessment.

Journal: Hematology (Amsterdam, Netherlands)
Published: June 23, 2025

Secondary Malignancies Following CAR T-Cell Therapy for B-Cell Malignancies: A Retrospective Analysis.

Secondary Malignancies Following CAR T-Cell Therapy for B-Cell Malignancies: A Retrospective Analysis.

Journal: EJHaem
Published: May 09, 2025

Title Not Found

Title Not Found

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Published: April 28, 2025
Showing 1-12 of 33

Last Updated: 09/26/2026